Articles

Our List of Articles

• Istvan Takacs, Heather Cooper, David D. Weaver and Michael J. Econs. 
  “Bone Mineral Density and Laboratory Evaluation of a Type II Autosomal Dominant Osteopetrosis Carrier.” 
  American Journal of Medical Genetics Volume 85 (1999): 9-12.

• Michael P. Whyte, Arkadi Chines, David P. Silva, Jr., Yvonne Landt, and Jack H. Ladenson. 
  “Creatine Kinase Brain Isoenzyme (BB-CK) Presence in Serum Distinguishes Osteopetroses Among the Sclerosing Bone Disorders.” 
  Journal of Bone and Mineral Research Volume 11 Number 18 (1996):. 1438-1443.
  
  
• L. Lyndon Key, Ramona Marie Rodriguiz, Steven M. Willi, Nancy M. Wright, Heather C. Heather, David R. Eyre, Joel K. Cure, Paul
P. Griffin, and William L. Ries. 
“Long-Term Treatment of Osteopetrosis with Recombinant Human Interferon Gamma.” 
The New England Journal of Medicine (1995): 1594-1599.


• Jens Bollerslev. 
  “Osteopetrosis:  a Genetic and Epidemiological Study.” 
  Clinical Genetics Volume 31 (1987): 86-90.
  
  
• Frederic Shapiro. 
  “Osteopetrosis:  Current Clinical Considerations.” 
  Clinical Orthopaedics and Related Research Number 294 (1993): 36-44.
  
  
• Frederick R. Singer and Stanley S. Chang. 
  “Osteopetrosis.” 
  Seminars in Nephrology Volume 12 Number 2 (March 1992): 191-199.
  
  
• Lyndon Key, David Carnes, Sessions Cole, Marijke Holtrop, Zvi Bar-Shavit, Fred Shapiro, Robert Arceci, James Steinberg, Caren Gundberg, Arnold Kahn, Steven Teitelbaum and Constantine Anast. 
  “Treatment of Congenital Osteopetrosis with High-Dose Calcitriol.” 
  The New England Journal of Medicine Volume 310 Number 7 (February 16, 1984): 409-415.
  
  
• Kenneth E. White, Daniel L. Koller, Istvan Takacs, Kenneth A. Buckwalter, Tatiana Foroud and Michael J. Econs. 
  “Locus Heterogeneity of Autosomal Dominant Osteopetrosis.” 
  The Journal of Clinical Endocrinology and Metabolism Volume 84 Number 3 (1999): 1047-1051.
  
  
• C. Conrad Johnston, Jr., Norman Lavy, Thomas Lord, Frank Vellios, A. Donald Merritt and William P. Deiss. 
  “Osteopetrosis:  a Clinical, Genetic, Metabolic and Morphologic Study of the Dominantly Inherited Benign Form.” 
  Medicine Volume 47 Number 1 (1968): 149-167.
  
  
• Wim Van Hul, Jens Bollerslev, Jeppe Gram, Els Van Hul, Wim Wuyts, Olivier Benichou, Filip Vanhoenacker and Patrick J. Willems.  “Localization of a Gene for Autosomal Dominant Osteopetrosis (Albers-Schonberg Disease) to Chromosome 1p21.” 
  American Journal of Human Genetics Volume 61 (1997): 363-369.
  
  
• Michael P. Whyte. 
  “Chipping Away at Marble Bone Disease.” 
  The New England Journal of Medicine Volume 332 Number. 24 (June 15, 1995): 1639-1640.
  
  
• Lyndon Key and William L. Reis. 
  “Osteopetrosis:  the Pharmaco-Physiologic Basis of Therapy.” 
  Clinical Orthopedics Volume 294 (1993): 85-9.
  
  
• Jens Bollerslev and P.E. Andersen. 
  “Radiological, Biochemical and Hereditary Evidence of Two Types of Autosomal Dominant Osteopetrosis.” 
  Bone Volume 9 (1998): 9-11.
  
  
• L. Lyndon Key, Jr., William L. Ries, Ramona M. Rodriguiz and Heather C. Hatcher. 
  “Recombinant Human Interferon Gamma Therapy for Osteopetrosis.” 
  The Journal of Pediatrics Volume 121 Number 1 (July 1992): 119-124.,
  
  
• Dennis M. Crockett, Robert B. Stanley and Rhonda Lubka. 
  “Osteomyelitis of the Maxilla in a Patient with Osteopetrosis.” 
  Otolaryngology – Head and Neck Surgery Volume 95 Number1 (July 1986): 117-120.
  
  
• Martin Steiner, Alan R. Gould and William R. Means. 
  “Osteomyelitis of the Mandible Associated with Osteopetrosis.” 
  Journal of Oral and Maxiofacial Surgery Volume 1 (1983): 395-405.
  
  
• E.J. Gerritsen, J.M. Vossen, A. Fasth, Friedrich W Morgan, G. Padmos et al., 
  “Bone Marrow Transplantation for Autosomal Recessive Osteopetrosis:  A Report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group.” 
  Journal of Pediatrics Volume 125 (1994):  896-901.
  
  
• H. Solh, A.M. DaCunha, N. Giri, A. Padmos, D. Spence, H. Clink et al.,  
  “Bone Marrow Transplantation for Infant Malignant Osteopetrosis.” 
  Journal of Pediatric Hematology and Oncology Volume 17 (1995): 350-55.
  
  
• J. Meletis, M. Samarkos, E. Michali, S. Vavourakis, C. Meletic, C. Poziopoulous et al., 
  “Correction of Anaemia and Thrombocytopenia in a Case of Adult Type I Osteopetrosis with Recombinant Human Erythropoietin (rHuEPO).” 
  British Journal of Hematology Volume 89 (1995): 911-913.
  
  
• R. Felix, W. Hofstetter and M. Cecchini. 
  “Recent Developments in the Understanding of the Pathophysiology of Osteopetrosis.” 
  European Journal of Endocrinology Volume 134 Number 2 (February 1996): 143-56.
  
  
• J.M. Charles and Lyndon Key. 
  “Developmental Spectrum of Children with Congenital Osteopetrosis.” 
  Journal of Pediatrics Volume 132 Number 2 (February 1998): 371-4.
  
  
• E.J. Gerritsen et al., 
  “Autosomal Recessive Osteopetrosis:  Variability of Findings at Diagnosis and During the Natural Course.” 
  Pediatrics Volume 93 Number 2 (February 1994): 247-53.
  
  
• Clair J. Beard, Lyndon Key, Peter E. Newburger, R. Alan B. Ezekowitz, Robert Arceci, Barbara Miller, Philip Proto, Thomas Ryan, Constantine Anast and Elizabeth R. Simons. 
  “Neutrophil Defect Associated with Malignant Infantile Osteopetrosis.” 
  The Journal of Laboratory and Clinical Medicine Volume 108 Number 5 (November 1986): 498-505.